Adeline Ledoux

发表

Novel Specific Metallo-β-Lactamase Inhibitor ANT2681 Restores Meropenem Activity to Clinically Effective Levels against NDM-Positive Enterobacterales

I. Morrissey, D. Davies, M. Lemonnier, 2021, Antimicrobial Agents and Chemotherapy.

Meropenem-ANT3310, a unique β-lactam-β-lactamase inhibitor combination with expanded antibacterial spectrum against Gram-negative pathogens including carbapenem-resistant Acinetobacter baumannii

Simon Leiris, Kirsty Holden, J. Bousquet, 2024, Antimicrobial agents and chemotherapy.